Regenerative medicine company Aziyo Biologics on Sept. 28 appointed Matthew Ferguson as CFO.
Three things to know:
1. Mr. Ferguson has more than 20 years of financial leadership experience with executive roles at medical device and biotechnology companies.
2. His resume includes a period as CFO, chief business officer and co-president at Avinger, a cardiovascular medical device company. Most recently, he served as CFO for Bossa Nova Robotics.
3. Aziyo Biologics' latest product launch was OsteoGro V, a viable cell bone matrix to assist with bone repair.